Ozoralizumab Completed Phase 1 Trials for Healthy Volunteers (HV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00916110Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects